Management of the PDA Trial
A phase 3 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 482 participants.
Also called NCT03456336
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 482 participants
- Registry
-
NCT03456336
-
- Other papers using this trial's data
- Expectant Management vs Medication for Patent Ductus Arteriosus in Preterm Infants: The PDA Randomized Clinical Trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (anticipated)
- Results first posted
- Countries
- United States
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT03456336. Randomized; no masking; primary purpose treatment. Start 2019-02-22 (actual); primary completion 2025-03-02 (actual). Results posted on 2026-05-12.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Management of the PDA Trial
- Acronym
- PDA
- Condition
- Infant, Premature
- Condition
- Patent Ductus Arteriosus
- Condition
- Infant, Newborn, Diseases
- Condition
- Patent Ductus Arteriosus After Premature Birth
- Intervention (Other)
- Active Treatment
- Intervention (Other)
- Expectant Management
- Lead sponsor
- NICHD Neonatal Research Network
- Collaborator
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Record details
- Record id
cardio:ct-nct03456336- Content hash
9550a632f0569efb0d2ea6e41aed055484ac9855e772fd206b458b65b02b57b0